Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • My Subscription
      • Subscribe Now
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » Smartwatches for the Diagnosis of Atrial Fibrillation
    STROKE ALERT

    Smartwatches for the Diagnosis of Atrial Fibrillation

    December 1, 2019
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share

    Related Articles

    Ablation of the Left Atrial Appendage for Long-standing, Persistent Atrial Fibrillation

    New Guidelines for the Treatment of Atrial Fibrillation

    Giving the Cold Shoulder to Drug Therapy for Atrial Fibrillation

    Related Products

    Pattern of Atrial Fibrillation Is Associated with Outcomes After Stroke

    New Tools for the Diagnosis of CJD

    Keywords

    stroke

    fibrillation

    atrial

    smartwatch

    By Matthew E. Fink, MD

    Louis and Gertrude Feil Professor and Chair, Department of Neurology, Associate Dean for Clinical Affairs, NYP/Weill Cornell Medical College

    Dr. Fink reports no financial relationships relevant to this field of study.

    SOURCE: Perez MV, Mahaffey KW, Hedlin H, et al, for the Apple Heart Investigators. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med 2019;381:1909-1917.

    I just bought a new Apple watch, and as I was setting it up, it asked me if I would like to register with Apple to receive notification if my watch picked up an abnormal heart rhythm. What should I do?

    The Apple Heart Study Investigators published their initial findings recently, and their report may give us more information that can help answer the question. The study participants were people without atrial fibrillation who purchased a smart phone app and consented to monitoring using a smartwatch-based irregular pulse notification algorithm, which identified possible atrial fibrillation. If notification occurred, the person was mailed an electrocardiography (ECG) patch to be worn for seven days to confirm the findings first identified by the smartwatch. Participants were surveyed 90 days after notification of irregular pulse and at the end of the study. The main objectives were to estimate the proportion of notified participants with atrial fibrillation diagnosed by an ECG patch, and the positive predictive value of a smartwatch identifying an irregular pulse.

    The investigators recruited 419,297 participants in less than a year and participants were monitored over a median of 117 days. A total of 2,161 participants (0.52%) received notifications of irregular pulse. Of the 450 participants who returned their ECG patches containing data for analysis, atrial fibrillation was identified in 34%, overall. In participants 65 years of age or older, atrial fibrillation was present in 35%. The positive predictive value for observing atrial fibrillation after an irregular pulse notification from a smartwatch, was 0.84. Of the 1,376 notified participants who returned a survey, 57% contacted their own healthcare providers outside of the study.

    The age distribution of this group is different than the usual cohort at risk for atrial fibrillation: 52% were between the ages of 22 and 39 years of age, and only 5.9% were 65 years or older. The group that purchased and wore smartwatches were considerably younger than patients at risk for atrial fibrillation or stroke. Therefore, the overall rate of notification, about one half of 1%, is quite low but applies largely to a healthy cohort of young people. A much more useful study would have included an older cohort that carries a higher risk of atrial fibrillation. What do we do with several hundred young people who had an irregular heart rate picked up by the smartwatch, but are otherwise in excellent health? Do we subject them to an expensive cardiac evaluation? Is this study good for the people who were being monitored, or is it good for Apple to encourage people to buy their smartwatch?

    What should I do? Well, since I am in the over-65 age group, and my mother had atrial fibrillation, I will sign up and become a participant.

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    Neurology Alert

    View PDF
    Neurology Alert (Vol. 39, No. 4) - December 2019
    December 1, 2019

    Table Of Contents

    Stereoelectroencephalography in Surgical Evaluation of Intractable Epilepsy

    Prognosis in Small Fiber Neuropathy

    Treating Depression in Epilepsy: To Medicate or Not?

    Patients With Stable Coronary Disease and Atrial Fibrillation Are Best Treated With Rivaroxaban, Alone

    What Is the Optimal Blood Pressure for Secondary Prevention of Stroke?

    Smartwatches for the Diagnosis of Atrial Fibrillation

    Dual Antiplatelet Therapy Results in Increase in Serious Hemorrhages Following TIA or Minor Stroke

    Begin Test

    Buy this Issue/Course

    Financial Disclosure: Neurology Alert’s Editor in Chief Matthew Fink, MD; Peer Reviewer M. Flint Beal, MD; Editorial Group Manager Leslie Coplin; Editor Jason Schneider; Executive Editor Shelly Morrow Mark; and Accreditations Manager Amy M. Johnson, MSN, RN, CPN, report no financial relationships relevant to this field of study.

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • My Subscription
      • Subscribe Now
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421 x 2

    International +1-404-262-5476 x 2

    Accounts Receivable

    1-800-688-2421 x 3
    ReliasMedia_AR@reliasmedia.com

    Sales

    1-800-688-2421 x 1

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2022 Relias. All rights reserved.

    Do Not Sell My Personal Information  Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing